Skip to main content
OpenTrials

Clinical trial condition

Infection, Human Immunodeficiency Virus I

Explore clinical trials studying Infection, Human Immunodeficiency Virus I. Study availability and eligibility vary by location and protocol.

16 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infection, Human Immunodeficiency Virus I trial results

Completed

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

NCT00046176

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 56 locations
View Trial Details
Completed

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

NCT00044577

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Oakland, California, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
View all 76 locations
View Trial Details
Completed

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

NCT01227824

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 101 locations
View Trial Details
Completed

Fosamprenavir Versus Other Protease Inhibitors

NCT00094523

Conditions
Infection, Human Immunodeficiency Virus I, Infections
Locations
  • GSK Investigational Site Beverly Hills, California, United States
  • GSK Investigational Site Fresno, California, United States
  • GSK Investigational Site Laguna Beach, California, United States
  • GSK Investigational Site Long Beach, California, United States
View all 52 locations
View Trial Details
Completed

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

NCT01263015

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Hobson City, Alabama, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Beverly Hills, California, United States
View all 145 locations
View Trial Details
Completed

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

NCT00242840

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • GSK Investigational Site Fort Lauderdale, Florida, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site Tampa, Florida, United States
  • GSK Investigational Site Atlanta, Georgia, United States
View Trial Details
Completed

GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults

NCT00257621

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
View Trial Details
Completed

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

NCT00082394

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Oakland, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 45 locations
View Trial Details

Related conditions